Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Follow-up Protocol for Subjects Treated With Adicet Allogeneic Gamma Delta (γδ) CAR T Cell Investigational Products

NCT04911478 is registered in ClinicalTrials.gov with Adicet Therapeutics as lead sponsor.

NCT NCT04911478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04911478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Follow-up Protocol for Subjects Treated With Adicet Allogeneic Gamma Delta (γδ) CAR T Cell Investigational Products
Lead sponsor
Adicet Therapeutics
Phase
Observational
Overall status
Active, not recruiting
Start date
February 14, 2022
Completion date
August 31, 2039
Enrollment
50 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b cell lymphoma, lymphoma, follicular, lymphoma, mantle-cell, lymphoma, non-hodgkin, marginal zone lymphoma, primary mediastinal b-cell lymphoma